- Home
- ACMR vs CNTA Comparison
ACMR vs CNTA Comparison
Compare ACMR & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACMR
- CNTA
- Stock Information
- Founded
- ACMR 1998
- CNTA 2020
- Country
- ACMR United States
- CNTA United Kingdom
- Employees
- ACMR N/A
- CNTA N/A
- Industry
- ACMR Industrial Machinery/Components
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- ACMR Technology
- CNTA Health Care
- Exchange
- ACMR Nasdaq
- CNTA Nasdaq
- Market Cap
- ACMR 2.5B
- CNTA 2.3B
- IPO Year
- ACMR 2017
- CNTA 2021
- Fundamental
- Price
- ACMR $41.45
- CNTA $23.96
- Analyst Decision
- ACMR Buy
- CNTA Strong Buy
- Analyst Count
- ACMR 4
- CNTA 9
- Target Price
- ACMR $34.67
- CNTA $31.75
- AVG Volume (30 Days)
- ACMR 995.0K
- CNTA 855.7K
- Earning Date
- ACMR 11-05-2025
- CNTA 11-12-2025
- Dividend Yield
- ACMR N/A
- CNTA N/A
- EPS Growth
- ACMR 31.61
- CNTA N/A
- EPS
- ACMR 1.66
- CNTA N/A
- Revenue
- ACMR $815,166,000.00
- CNTA $15,000,000.00
- Revenue This Year
- ACMR $18.90
- CNTA N/A
- Revenue Next Year
- ACMR $16.78
- CNTA N/A
- P/E Ratio
- ACMR $24.97
- CNTA N/A
- Revenue Growth
- ACMR 17.53
- CNTA 118.88
- 52 Week Low
- ACMR $13.87
- CNTA $9.60
- 52 Week High
- ACMR $45.12
- CNTA $25.42
- Technical
- Relative Strength Index (RSI)
- ACMR 56.76
- CNTA 55.73
- Support Level
- ACMR $40.13
- CNTA $23.45
- Resistance Level
- ACMR $42.92
- CNTA $25.31
- Average True Range (ATR)
- ACMR 1.80
- CNTA 0.97
- MACD
- ACMR -0.12
- CNTA -0.00
- Stochastic Oscillator
- ACMR 72.83
- CNTA 54.41
About ACMR ACM Research Inc.
ACM Research Inc supplies advanced, innovative capital equipment developed for the world-wide semiconductor industry. Fabricators of advanced integrated circuits, or chips, can use its wet-cleaning and other front-end processing tools in numerous steps to improve product yield, even at increasingly advanced process nodes. It has designed these tools for use in fabricating foundry, logic and memory chips, including dynamic random-access memory, or DRAM, and 3D NAND-flash memory chips. The company also develops, manufactures and sells advanced packaging tools to wafer assembly and packaging customers.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.